Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 13.
doi: 10.1007/s00259-025-07395-9. Online ahead of print.

Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment

Cecilia Boccalini  1 , Luisa Knappe  2 , Gregory Mathoux  2 , Debora Elisa Peretti  1 , Federica Ribaldi  3   4 , Francesca B Pizzini  5 , Linjing Mu  6 , Max Scheffler  7 , Giovanni B Frisoni  3   4 , Valentina Garibotto  8   9   10
Affiliations

Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment

Cecilia Boccalini et al. Eur J Nucl Med Mol Imaging. .
No abstract available

Keywords: Alzheimer’s disease; Fluorodeoxyglucose positron emission tomography; Limbic age-related TDP-43 encephalopathy; Mild cognitive impairment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: VG received research support and speaker fees through her institution from Healthcare, Siemens Healthineers, Novo Nordisk. Janssen and Novartis. GBF has received support, payment, consulting fees, or honoraria through his institution for lectures, presentations, speaker bureaus, manuscript writing, or educations events from: Biogen, Roche, Diadem, Novo Nordisk, GE Healthcare, OM Pharma, and Eisai. Human ethics and consent to participate: This study was performed in line with the principles of the Declaration of Helsinki and the subjects’ consent has been waived from all participants. Ethics approval: The study’s protocol has been approved by our local Geneva Ethics Committee (Cantonal Research Ethics Commission, Geneva, Switzerland) (NO 2016–01346). Clinical trial number: not applicable.

References

    1. Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol Elsevier. 2014;13:614–29. - DOI
    1. Serrano-Pozo A, Qian J, Monsell SE, et al. Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Ann Neurol Wiley Online Libr. 2014;75:597–601. - DOI
    1. Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Volume 142. Brain: Oxford University Press; 2019. pp. 1503–27.
    1. Mikhailenko E, Colangelo K, Tuimala J, et al. Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study. Brain. Oxford University Press UK; Epub 2024.:awae212.
    1. Josephs KA, Whitwell JL, Weigand SD, et al. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease. Acta Neuropathol. 2014;127:811–24. - DOI - PubMed - PMC

LinkOut - more resources